Publications
Publications
Wohlfart, S., Roettgen, H., Junker, N., Augustin, V. A., Ackermann, B. C., Geisweid, L., … & Hammer, M. (2026). Vitrectomy Status Alters Early Intravitreal Drug Distribution: An Ex Vivo PET-CT Study. Investigative Ophthalmology & Visual Science, 67(8), 36.
Karaivanova, M., Łabuz, G., Zielińska, A., Wu, Z., Britz, L., Wohlfart, S., … & Hammer, M. (2026). The Effect of the Capsular Bag on the Optical Performance of an IOL Measured in an Ex Vivo Model. Investigative Ophthalmology & Visual Science, 67(3), 46-46.
Ackermann, B. C., Junker, N., Friedrich, M., Jørstad, Ø. K., Moe, M. C., Augustin, V. A., … & Hammer, M. (2026). The effect of syringe design and cannula dimensions on time-force curve in intravitreal injection across different drug viscosities: area under the curve and peak injection force. International Journal of Retina and Vitreous.
Hammer, M., Geisweid, L., Junker, N., Wohlfart, S., Skrzypczyk, L., Ackermann, B. C., … & Uhl, P. (2026). In-Depth Analysis of the Intravitreal Biocompatibility of Polyethylene Glycol of Different Molecular Weight in an In Vivo Porcine Model. Investigative Ophthalmology & Visual Science, 67(2), 37-37.
Hammer, M., Skrzypczyk, L., Wohlfart, S., Ackermann, B. C., Geisweid, L., Pohl, S. W., … & Uhl, P. (2026). Methotrexate‐Loaded Liposomal Formulation Enables 6‐Week Sustained Intraocular Therapeutic Drug Release in a Porcine Model. Advanced Healthcare Materials, 15(1), e03230.
Hammer, M., Ie, A., Eibenberger, K., Auffarth, G. U., & Xue, K. (2025). An analysis of heavy silicone oil treatment for inferior proliferative vitreoretinopathy. BMC ophthalmology, 25(1), 38.
Skrzypczyk, L., Ackermann, B. C., Augustin, V. A., Rahn, U., Uhl, P., Auffarth, G. U., & Hammer, M. (2025). An in-depth characterization of development-related electroretinographical and morphological changes in Landrace pigs. Documenta Ophthalmologica, 151(3), 219-228.
Muuss, M., Karaivanova, M., Skrzypczyk, L., Wohlfart, S., Herth, J., Uhl, P., … & Hammer, M. (2025). F4H5 Alleviates Increased Outflow Resistance Induced by Emulsified Silicone Oil In Vitro. Investigative Ophthalmology & Visual Science, 66(11), 21-21.
Hammer, M., Teich, L., Friedrich, M., Reitemeyer, E., Britz, L., Khoramnia, R., … & Auffarth, G. U. (2025). Cataract surgery in the extremely small eye: morphology, comorbidities and outcomes in 300 eyes. British Journal of Ophthalmology, 109(8), 917-924.
Reitemeyer, E. V., Hammer, M., Schmidt-Bacher, A., Auffarth, G. U., & Feltgen, N. (2025). Ein (un) klassisches venöses Ereignis. Klinische Monatsblätter für Augenheilkunde, 242(09), 878-880.
Hammer, M., Britz, L., Auffarth, G. U., & Kleinmann, G. (2025). Fixation of a new implantable miniature telescope in the absence of capsular support: sulcus-fixated frame. JCRS Online Case Reports, 13, e00187.
Hammer, M., Britz, L., Böhmann, M. B., Herbster, L., Muuss, M., Herth, J., … & Auffarth, G. U. (2025). Early silicone oil opacification in the absence of emulsification is caused by an increased level of silicone dioxide. Retina, 45(3), 491-500.
Hammer, M., Junker, N., Reitemeyer, E. V., Auffarth, G. U., Augustin, V. A., & Feltgen, N. (2025). Das Licht der Welt–rätselhafte Skotome nach Kaiserschnitt. Klinische Monatsblätter für Augenheilkunde, 242(12), 1165-1168.
Wohlfart, S., Herth, J., Böhmann, M. B., Pander, G., Herbster, L., Mier, W., … & Hammer, M. (2024). Exposure to silicone oil endotamponades induces VEGF antibody aggregation and loss of functionality. Investigative Ophthalmology & Visual Science, 65(13), 56-56.
Hammer, M., Muuss, M., Schickhardt, S., Scheuerle, A., Khoramnia, R., Łabuz, G., … & Auffarth, G. U. (2024). Forward light scattering of the vitreous gel after enzymatic aging: an in vitro model to study vitreous opacification. Investigative Ophthalmology & Visual Science, 65(3), 36-36.
Britz, L., Hammer, M., Łabuz, G., Zielinska, A., Jester, F., Freudenberg, J., … & Yildirim, T. M. (2024). Impact of Calcium and Phosphorus Levels on Optical Deterioration in Primary and Secondary Intraocular Lens Calcification. Translational Vision Science & Technology, 13(10), 18-18.
Birtel, J., Hammer, M., Feltgen, N., Pauleikhoff, L., Ong, A. Y., Geerling, G., … & Issa, P. C. (2024). Intravitreal injections: improving sustainability by reducing clinical waste. Klinische Monatsblätter für Augenheilkunde, 241(10), 1156-1162.
Hammer, M., Muuss, M., Herbster, L., Herth, J., Scheuerle, A., Khoramnia, R., … & Auffarth, G. U. (2024). Viscoelastic, optical, and surgical properties of vitreous body replacement hydrogels after aging compared to porcine vitreous bodies and silicone oils. Translational Vision Science & Technology, 13(7), 5-5.
Hammer, M., Herth, J., Herbster, L., Böhmann, M. B., Muuss, M., Khoramnia, R., … & Uhl, P. (2024). In vitro physicochemical and pharmacokinetic properties of bevacizumab dissolved in silicone oils compared to hydrogel-substitutes and porcine vitreous bodies. Gels, 10(8), 501.
Hammer, M., Britz, L., Schickhardt, S., Munro, D., Khoramnia, R., Scheuerle, A., … & Auffarth, G. U. (2024). Straylight of explanted silicone oil samples to predict emulsification. Ophthalmology Science, 4(6), 100558.
Hammer, M., Heggemann, Y., & Auffarth, G. U. (2024). Dynamic Stimulation Aberrometry: Objectively Measured Accommodation and Pupil Dynamics after Phakic Iris-Fixated Intraocular Lens Implantation. Ophthalmology Science, 4(2), 100374.
Hammer, M., Herth, J., Muuss, M., Schickhardt, S., Scheuerle, A., Khoramnia, R., … & Auffarth, G. U. (2023). Forward light scattering of first to third generation vitreous body replacement hydrogels after surgical application compared to conventional silicone oils and vitreous body. Gels, 9(10), 837.
Hammer, M., Schickhardt, S., Munro, D., Scheuerle, A., Khoramnia, R., Uhl, P., & Auffarth, G. U. (2023). New approaches to explanting high-viscosity silicone oil in retinal surgery—polyimide cannulas vs extraction sleeves vs a luer-trocar. International Journal of Retina and Vitreous, 9(1), 43.
Hammer, M., Schickhardt, S., Zhang, L., Munro, D., Yildirim, T. M., & Auffarth, G. U. (2023). Capsule Dynamics, Implantation, and Explantation of the Smaller Incision, New-Generation Implantable Miniature Telescope: a Miyake–Apple Study. Retina, 43(12), 2183-2188.
Hammer, M., Schickhardt, S. K., Merz, P. R., Khoramnia, R., Scheuerle, A. F., Mier, W., … & Auffarth, G. U. (2022). Intravitreal application: physicochemical properties of drugs dissolved in silicone oils of different density in comparison to the porcine vitreous body. Pharmaceutics, 14(7), 1364.
Hammer, M., Heggemann, Y., & Auffarth, G. U. (2023). Introducing dynamic stimulation aberrometry: binocular objective accommodation versus subjective measures. Ophthalmology Science, 3(4), 100309.
Hammer, M., Schickhardt, S., Munro, D. J., Scheuerle, A., Mayer, C. S., & Auffarth, G. U. (2022). Physicochemical properties of explanted silicone oil after use as an intraocular tamponade. Translational Vision Science & Technology, 11(2), 3-3.
Hammer, M., Schickhardt, S. K., Munro, D., Khoramnia, R., Scheuerle, A., Mayer, C. S., & Auffarth, G. U. (2022). The novel use of high-flow polyimide cannulas to improve silicone oil injectability in vitreoretinal surgery. Retina, 42(6), 1170-1175.
Van de Wiele, V. L., Hammer, M., Parikh, R., Feldman, W. B., Sarpatwari, A., & Kesselheim, A. S. (2022). Competition law and pricing among biologic drugs: the case of VEGF therapy for retinal diseases. Journal of Law and the Biosciences, 9(1), lsac001.
To be updated soon
PRIZES
| 2023 | Winner of the Science4Life Venture Cups, a Germany-wide start-up and idea-competition, Team: „VitreoSub“ – innovative tamponades for retinal surgery |
| 2023 | Best Free Paper Awards at DGII 2023 – Category “Multifocal and accommodating IOLs” DOC 2023 – Category „Retina“ DOC 2022 – Category „Retina“ and „General Ophthalmology” Ophthalmochirurgen in der Kategorie „Retina“ |
| 2023 | Finalist and winner of the audience award at Hei_Innovation – start-up and Idea competition of Heidelberg University for the project „A hydrogel vitreous body replacement strategy” |
GRANTS
| 2023 | Add-On Fellowship for Life Sciences, Joachim-Herz Stiftung, 12 500 € for developing individual skills |
| 2023 | Dr. Hans Messer Stiftung „Glaskörperersatzstoffe als Drug Delivery Systeme für die Netzhautchirurgie“ |
| 2022 | Ernst und Berta Grimmke-Stiftung „Mittels Click-Reaktion wird ein neuartiger Glaskörperersatzstoff entwickelt, welcher gleichzeitig als Medikamentenreservoir bei Netzhauterkrankungen fungieren soll“ |





